If you are wondering whether PPL is still a sensible buy at today’s price or if the easy money has already been made, you are not alone. The valuation story is more nuanced than the headline numbers ...
PeptiDream (TSE:4587) just logged two meaningful scientific wins, advancing an oral dual IL 17 program into its clinical portfolio and hitting a preclinical siRNA delivery milestone with Alnylam, ...
Recent changes to the H-1B visa vetting process have left many Indian workers stranded in India after their visa appointments were suddenly cancelled or delayed by several months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback